These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9656399)

  • 21. Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria.
    Riopel J; Tam M; Mohan K; Marino MW; Stevenson MM
    Infect Immun; 2001 Jan; 69(1):129-36. PubMed ID: 11119498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines.
    Rössner P; Bubeník J; Sobota V; Indrová M; Hájková R; Mendoza L; Jandlová T; Símová J
    Folia Biol (Praha); 1999; 45(5):173-7. PubMed ID: 10730885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action.
    Simmons AD; Li B; Gonzalez-Edick M; Lin C; Moskalenko M; Du T; Creson J; VanRoey MJ; Jooss K
    Cancer Immunol Immunother; 2007 Oct; 56(10):1653-65. PubMed ID: 17410360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
    Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF.
    Zhang HH; Basu S; Wu F; Begley CG; Saris CJ; Dunn AR; Burgess AW; Walker F
    J Leukoc Biol; 2007 Oct; 82(4):915-25. PubMed ID: 17652450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
    Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
    Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.
    von Mehren M; Arlen P; Gulley J; Rogatko A; Cooper HS; Meropol NJ; Alpaugh RK; Davey M; McLaughlin S; Beard MT; Tsang KY; Schlom J; Weiner LM
    Clin Cancer Res; 2001 May; 7(5):1181-91. PubMed ID: 11350882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.
    Eksioglu EA; Mahmood SS; Chang M; Reddy V
    Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioimmunotherapy of rodent malaria: co-treatment with recombinant mouse granulocyte-macrophage colony-stimulating factor and an enkephalin fragment peptide Tyr-Gly-Gly.
    Kaur A; Kinhikar AG; Singh PP
    Acta Trop; 2004 Jun; 91(1):27-41. PubMed ID: 15158686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
    J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice.
    Stämpfli MR; Wiley RE; Neigh GS; Gajewska BU; Lei XF; Snider DP; Xing Z; Jordana M
    J Clin Invest; 1998 Nov; 102(9):1704-14. PubMed ID: 9802884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
    Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
    Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracerebral granulocyte-macrophage colony-stimulating factor induces functionally competent dendritic cells in the mouse brain.
    Mausberg AK; Jander S; Reichmann G
    Glia; 2009 Sep; 57(12):1341-50. PubMed ID: 19229994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of mice from malaria after co-administration of recombinant mouse granulocyte-macrophage colony- stimulating factor and methionine-enkephalin.
    Singh PP; Singh S
    Eur Cytokine Netw; 2001; 12(3):528-36. PubMed ID: 11566634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
    Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor.
    Yang YH; Hamilton JA
    Arthritis Rheum; 2001 Jan; 44(1):111-9. PubMed ID: 11212148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.